In addition, we found a striking difference between the amount of comorbid pathology, such as LBs, TDP-43 or vascular pathology, present in our original resilient samples and all AD samples that matched our inclusion criteria (Fig. 1). This evidence concerns the gene TARDBP and Alzheimer disease.